Collection of Blood Samples From SMART Study Participants for Future Genetic Studies

NCT ID: NCT00377169

Last Updated: 2016-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

3261 participants

Study Classification

OBSERVATIONAL

Study Completion Date

2006-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to collect blood samples from SMART study participants to use in future genetic studies.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Despite progress in the treatment of HIV and a greater understanding of the pathophysiology of HIV infection, there are still unexplained differences in both the progression of untreated HIV infection and response to antiretroviral therapy. These differences are likely related to the unique genetic makeup of individuals with HIV infection. Particular genes may offer protection against HIV infection, while other genes may make disease progression more likely. Knowing more about the genetic makeup of HIV infected individuals may lead to the development of a targeted treatment strategy based on an individual's specific risk of disease progression and sensitivity to medication toxicity. The purpose of this substudy is to collect blood samples from SMART study participants. The samples will be used in future Community Programs for Clinical Research on AIDS (CPCRA) studies investigating the link between human genetic factors and clinical outcome data.

This study will enroll individuals currently participating in the SMART study. Participants will provide one blood sample. Individual test results from future blood analyses will not be provided to a patient unless they may have profound health implications for that patient.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

HIV Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Treatment Experienced

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Coenrollment in the SMART study
* Parent or guardian willing to provide informed consent, if applicable
Minimum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Community Programs for Clinical Research on AIDS

NETWORK

Sponsor Role collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jonathan Uy, MD

Role: STUDY_CHAIR

AIDS Research Alliance Chicago (ARAC), University of Illinois at Chicago

Roberto Arduino, MD

Role: STUDY_CHAIR

The University of Texas Health Science Center, Houston

Fraser Drummond, MBChB, MRCA, DA (UK)

Role: STUDY_CHAIR

National Centre in HIV Epidemiology and Clinical Research, University of New South Wales

Daniela Gey, MD

Role: STUDY_CHAIR

Copenhagen HIV Programme, Hvidovre University Hospital

Adrian Palfreeman, MD

Role: STUDY_CHAIR

Peterborough and Stamford Hospitals NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AltaMed Health Services Corporation

Los Angeles, California, United States

Site Status

Los Angeles Gay & Lesbian Community Service Center

Los Angeles, California, United States

Site Status

VA Greater Los Angeles Healthcare System

Los Angeles, California, United States

Site Status

VA Greater Loss Angeles Healthcare System

Los Angeles, California, United States

Site Status

Comprehensive Care Center/North Broward Hospital

Fort Lauderdale, Florida, United States

Site Status

Hillsborough County Health Department

Tampa, Florida, United States

Site Status

Absolute Care Clinic

Atlanta, Georgia, United States

Site Status

AID Atlanta/Morehouse Medical School Ryan White Cl

Atlanta, Georgia, United States

Site Status

AIDS Research Consortium of Atlanta (ARCA) Central

Atlanta, Georgia, United States

Site Status

Dr. Dennis Melton (private practice)

Atlanta, Georgia, United States

Site Status

Dr. Melanie Thompson and Dr. Annette Bernard (private practice)

Atlanta, Georgia, United States

Site Status

Dr. Richard Hudson (private practice)

Atlanta, Georgia, United States

Site Status

Mayo Clinic/CORNET

Rochester, Minnesota, United States

Site Status

SUNY Downstate Medical Center

Brooklyn, New York, United States

Site Status

Westchester Medical Center/New York Medical College

Valhalla, New York, United States

Site Status

University of North Texas Health Science Center

Fort Worth, Texas, United States

Site Status

Froedtert and Medical College I.D. Clinic

Milwaukee, Wisconsin, United States

Site Status

Gladstone Road Medical Centre

Highgate Hill, , American Samoa

Site Status

Royal Melbourne Hospital

Parkville, Victoria, Australia

Site Status

Royal Perth Hospital

Perth, , Australia

Site Status

Westmead Hospital

Westmead, , Australia

Site Status

C.H.U. St. Pierre Center Hospitalier Universitaire

Brussels, , Belgium

Site Status

Clinique Medicale L'actuel

Montreal, Quebec, Canada

Site Status

Fundacion Arriaran Santa Elvira

Santiago, , Chile

Site Status

Arbus Universitetshospital, Skejby Department of Infectious Diseases

Brendstrupgaardvej Aarhus, , Denmark

Site Status

Helsinki University Central Hospital

Helsinki, , Finland

Site Status

University Hospital Koln (Cologne)

Cologne, , Germany

Site Status

J.W. Goethe University Hospital

Frankfurt, , Germany

Site Status

ifi Institut

Hamburg, , Germany

Site Status

Infektionsambulanz und Tagesklinik Poliklinik Innenstadt der

Munich, , Germany

Site Status

AIDS Medical Center, International Medical Center

Tokyo, , Japan

Site Status

University Hospital Center Ibn Rochd

Casablanca, , Morocco

Site Status

Wellington Hospital

Newtown, Wellington Region, New Zealand

Site Status

Christchurch Hospital

Christchurch, , New Zealand

Site Status

Waikato Hospital

Hamilton, , New Zealand

Site Status

Wroclaw University School of Medicine

Koszarawa, , Poland

Site Status

Centro Hospital de Cascais

Cascais, , Portugal

Site Status

Hospital de Santa Maria

Lisbon, , Portugal

Site Status

Hospital Joaquim Urbano

Porto, , Portugal

Site Status

Medizinische Universitatsklinik

Bonn, , The Gambia

Site Status

Klinikum der Ruprecht-Karis-Universitat (U. Hospit)

Heidelberg, , The Gambia

Site Status

Catedra de Enfermedades Infecciosas

Montevideo, , Uruguay

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States American Samoa Australia Belgium Canada Chile Denmark Finland Germany Japan Morocco New Zealand Poland Portugal The Gambia Uruguay

Related Links

Access external resources that provide additional context or updates about the study.

http://clinicaltrials.gov/show/NCT00027352

Click here for more information on CPCRA 065

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SMART

Identifier Type: -

Identifier Source: secondary_id

CPCRA 065H

Identifier Type: -

Identifier Source: org_study_id